Why Fresenius Medical Care AG’s (FMS) Stock Is Down 5.49%
As of Wednesday, October 07, Fresenius Medical Care AG’s FMS share price has dipped by 5.49%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
Cynthia McLaughlin
Michael Rose
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | FMS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,361.4 | $1,743.0 | 79% |
|
| Shares Out (Mil) | 298.6 | 80.6 | 82% |
|
| Institutional Ownership | 99.9% | 87.5% | 96% |
|
| Float (Mil) | 203.5 | 59.2 | 74% |
|
| Beta | 0.79 | 0.75 | 46% |
|
| Avg Daily Volume (000s) | 2,001 | 622 | 81% |
|
| Price Change (52-week) |
(12.3%) | 75.6% | 42% |
|
| Growth | FMS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.1% | 10.4% | 21% |
|
| Net Income (5yr) | (4.2%) | (0.5%) | 35% |
|
| EPS (5yr) | (4.0%) | 3.0% | 26 |
|
| Dividends (5yr) | 1.3% | 0.0% | 87% |
|
| Cash Flow (5yr) | 41.5% | (17.4%) | 91% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 5 | 5 | |
| Current EPS | $0.510 | $2.708 | $2.570 | |
| Month Ago EPS | $0.971 | $4.437 | $4.671 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $1.017 | $4.449 | $4.759 | |
| Year/Year Chg | (26.1%) | (31.4%) | (15.5%) | |
| Financials | FMS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $22,120 | $1,529 | 92% |
|
| Net Income (TTM) (Mil) | $934 | $33 | 85% |
|
| EPS (TTM) | $3.421 | $0.300 | 80% |
|
| Operating Cash Flow (TTM) (Mil) | $3,278 | $175 | 92% |
|
| Net Cash Flow (TTM) (Mil) | ($172) | $7 | 11% |
|
| Long-Term Debt (Q1) (Mil) | $8,985 | $419 | 90% |
|
| Enterprise Value (Q1) (Mil) | $23,948 | $2,427 | 85% |
|
| Valuation | FMS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.36 | 2.63 | 8% |
|
| P/E | 5.9 | 26.0 | 7% |
|
| Dividend Yield | 4.3% | 0.0% | 90% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | FMS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 26.5% | 27.3% | 30% |
|
| Net Margin | 4.2% | 1.4% | 44% |
|
| ROA | 2.6% | 2.4% | 58% |
|
| ROE | 6.3% | 7.3% | 46% |
|
| Liabilities to Assets | 56.3% | 62.3% | 50% |
|
| F-Score | 8 | 5 | 93% |
|
Passing Stock Screens
As of 11/19/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 2.8% |
| +/- S&P 500: | -4.6 |
| Performance Since Inception: | 2.1% |
| +/- S&P 500: | -5.3 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors